Gary D. Rubin - Jul 1, 2024 Form 4 Insider Report for bioAffinity Technologies, Inc. (BIAF)

Role: Director, 10%+ Owner
Signature: /s/ Maria Zannes, as attorney-in-fact for Gary D. Rubin
Stock symbol: BIAF
Transactions as of: Jul 1, 2024
Transactions value $: $0
Form type: 4
Date filed: 7/2/2024, 06:47 PM
Previous filing: Jun 14, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIAF	Common Stock	Award	$0	+33.8K	+29.95%	$0.00	147K	Jul 1, 2024	Direct	F1
holding	BIAF	Common Stock						1.58M	Jul 1, 2024	By Trust	F2

Showing 1 to 2 of 2 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant of restricted shares of common stock, par value $0.007 per share, that vest pro rata on a monthly basis for 12 months commencing on August 1, 2024.
F2	Represents shares of common stock owned directly by the Harvey Sandler Revocable Trust (the "Trust"), a 10% owner of the Issuer, and indirectly by Mr. Rubin, as co-trustee of the Trust. Mr. Rubin disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.